2care4 is a prominent European pharmaceutical company headquartered in Denmark, specializing in the parallel import, repackaging, and distribution of originator medicines. By sourcing pharmaceuticals from countries within the European Economic Area (EEA) where they are sold at lower prices and then repackaging them for other EEA markets, 2care4 aims to increase the accessibility and affordability of medicines for patients and healthcare systems. The company operates with a strong focus on quality, safety, and regulatory compliance, adhering to Good Distribution Practice (GDP) and Good Manufacturing Practice (GMP) standards. 2care4 serves pharmacies, hospitals, and pharmaceutical wholesalers across several European countries.
The Roskilde headquarters serves as the central operational and administrative hub, overseeing strategic planning, regulatory affairs, quality assurance, finance, and logistics coordination for the company's Europe-wide parallel import activities.
The facility is equipped with modern pharmaceutical warehousing, including climate-controlled storage and advanced repackaging lines, designed to meet strict EU GxP (Good Practice) guidelines. It likely incorporates robust security systems for handling pharmaceutical products.
The work culture at 2care4's headquarters is expected to be professional, quality-driven, and collaborative, emphasizing precision, regulatory compliance, and efficiency in a dynamic international market. Employees likely contribute to a mission of making healthcare more accessible.
The headquarters' location in Denmark provides strategic access to the European pharmaceutical market and a strong regulatory environment. It's central to managing the complex supply chain and legal framework inherent in parallel pharmaceutical trade.
2care4 has a significant presence across Europe, primarily focused on the parallel import and distribution of pharmaceuticals within the European Economic Area (EEA). Key functions supported across its European operations include sourcing affordable medicines, meticulous repackaging and relabeling according to national requirements, stringent quality control, navigating complex regulatory approvals, and efficient distribution to pharmacies, hospitals, and wholesalers in countries such as Denmark, Germany, Sweden, Norway, and other European markets.
Langebjergvaenget 4
Roskilde
Region Zealand
Denmark
Address: Tempowerkring 1a, 21079 Hamburg
To provide the German healthcare system and patients with access to a broader range of affordable medicines through parallel trade.
Address: Postboks 1520 Vika, 0117 Oslo (Note: PO Box Address)
To facilitate the supply and availability of parallel imported medicines in the Norwegian market.
Address: Svärdvägen 11D, 182 33 Danderyd
To cater to the Swedish demand for cost-effective medicines by leveraging parallel importation opportunities.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, 2care4 Group' leadership includes:
2care4 Group has been backed by several prominent investors over the years, including:
No major publicly announced executive hires or exits for the core group leadership team have been identified in the last 12 months. The executive team appears stable based on available public information.
Discover the tools 2care4 Group uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Common email formats at 2care4 likely follow standard professional patterns. While multiple formats might be in use, a frequent structure is combining parts of an employee's name with the company domain.
[first].[last]@2care4.dk
Format
toke.vaerndal@2care4.dk
Example
75%
Success rate
2care4.dk Official Website • November 20, 2023
2care4 announced the acquisition of the AI solution TYKIS. This tool is designed for handling and structuring large amounts of data for tenders, aiming to strengthen 2care4's capabilities in data analysis and tender processes....more
2care4.dk Official Website • May 30, 2023
The 2care4 Group acquired the ophthalmology portfolio from Danish pharmaceutical company Pharmacosmos A/S. This portfolio includes established eye drops for glaucoma and dry eyes, significantly strengthening 2care4's offering in the Nordic ophthalmology market....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including 2care4 Group, are just a search away.